You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

ICN Pharmaceuticals, Inc. v. Bristol-Myers Co.

Citations: 245 A.D.2d 182; 666 N.Y.S.2d 185; 1997 N.Y. App. Div. LEXIS 13151

Court: Appellate Division of the Supreme Court of the State of New York; December 17, 1997; New York; State Appellate Court

Narrative Opinion Summary

Order from the Supreme Court, New York County, dated October 8, 1996, affirmed the denial of the defendant’s motion to dismiss the complaint based on collateral estoppel and res judicata. The court found that the prior arbitration, which determined the defendant had materially breached the Supply Agreement, did not resolve whether the plaintiff’s predecessor was entitled to a return of the advance fee under the License Agreement. The arbitrators explicitly noted they were not addressing issues related to the License Agreement, as it was deemed non-arbitrable. Consequently, the arbitration award does not invoke collateral estoppel or res judicata principles. The defendant's prior assertion that the advance fee claims were not arbitrable binds it to the doctrine of judicial estoppel. The decision was unanimously concurred by Justices Ellerin, Wallach, Mazzarelli, Andrias, and Colabella.

Legal Issues Addressed

Collateral Estoppel and Res Judicata

Application: The court determined that collateral estoppel and res judicata do not apply because the prior arbitration did not resolve the issue of the plaintiff’s entitlement to a return of the advance fee under the License Agreement.

Reasoning: The court found that the prior arbitration, which determined the defendant had materially breached the Supply Agreement, did not resolve whether the plaintiff’s predecessor was entitled to a return of the advance fee under the License Agreement.

Judicial Estoppel

Application: The defendant is bound by the doctrine of judicial estoppel due to its prior assertion that the advance fee claims were not subject to arbitration.

Reasoning: The defendant's prior assertion that the advance fee claims were not arbitrable binds it to the doctrine of judicial estoppel.

Non-arbitrability of License Agreement Issues

Application: The arbitration panel did not address issues related to the License Agreement, as these were considered non-arbitrable, affecting the applicability of collateral estoppel and res judicata.

Reasoning: The arbitrators explicitly noted they were not addressing issues related to the License Agreement, as it was deemed non-arbitrable.